Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization

por Tan CS, Sadda SR
Publicado 2017

Quantifying Conflict of Interest in the Choice of Anti-VEGF Agents

por Browning DJ, Greenberg PB
Publicado 2021

Polypoidal choroidal vasculopathy (PCV): the 4-year review of the real-life treatment experiences

por Ratanasukon M, Bhurayanontachai P, Jirarattanasopa P
Publicado 2018

Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients

por Abu-Yaghi NE, Abed AM, Khlaifat DF, Nawaiseh MB, Emoush LO, AlHajjaj HZ, Abojaradeh AM, Hattar MN, Abusaleem SK, Sabbagh HM, Abu Gharbieh YA, Quaqazeh SA
Publicado 2020

Side Effects of Brolucizumab

por Tahmineh Motevasseli, Saeed Mohammadi, Fatemeh Abdi, William R. Freeman
Publicado 2021

Evaluation of the Safety of Bilateral Same-Day Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents: Experience of a Large Korean Retina Center

por Jang K, Ahn J, Sohn J, Hwang DDJ
Publicado 2020

Treatment patterns in diabetic macular edema in Taiwan: a retrospective chart review

por Sheu SJ, Cheng CK, Kuo HK, Tsai CY, Lin TC, Tan J, Chandwani H, Adena M, Chen SJ
Publicado 2018

A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK

por Hykin P, Chakravarthy U, Lotery A, McKibbin M, Napier J, Sivaprasad S
Publicado 2016

The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intr...

por Amy S. Babiuch, Charles C. Wykoff, Sari Yordi, Hannah Yu, Sunil K. Srivastava, Ming Hu, Thuy K. Le, Leina Lunasco, Jamie Reese, Muneeswar G. Nittala, SriniVas R. Sadda, Justis P. Ehlers
Publicado 2021

Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration

por Wingard JB, Delzell DAP, Houlihan NV, Lin J, Gieser JP
Publicado 2019

Integrated results from the COPERNICUS and GALILEO studies

por Pielen A, Clark WL, Boyer DS, Ogura Y, Holz FG, Korobelnik JF, Stemper B, Asmus F, Rittenhouse KD, Ahlers C, Vitti R, Saroj N, Zeitz O, Haller JA
Publicado 2017

Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration

por Cheema MR, DaCosta J, Talks J
Publicado 2021

Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization

por Figueira J, Henriques J, Carneiro Â, Marques-Neves C, Flores R, Castro-Sousa JP, Meireles A, Gomes N, Nascimento J, Amaro M, Silva R
Publicado 2021

Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome

por Chung WH, van Dijk EHC, Mohabati D, Dijkman G, Yzer S, de Jong EK, Fauser S, Schlingemann RO, Hoyng CB, Boon CJF
Publicado 2016

Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab

por Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS
Publicado 2016

Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema

por Dweikat A, Jarrar A, Akkawi M, Shehadeh M, Aghbar A, Qaddumi J, Akkawi M
Publicado 2021

Short-Term Effects of COVID-19-Related Deferral of Intravitreal Injection Visits

por Ashkenazy N, Goduni L, Smiddy WE
Publicado 2021

Choroidal Neovascularization in Pediatric Patients: Analysis of Etiologic Factors, Clinical Characteristics and Treatment Outcomes

por Ting Zhang, Ting Zhang, You Wang, You Wang, Wenjia Yan, Wenjia Yan, Yafen Liu, Yafen Liu, Jinglin Lu, Jinglin Lu, Limei Sun, Limei Sun, Songshan Li, Songshan Li, Li Huang, Li Huang, Zhaotian Zhang, Zhaotian Zhang, Xiaoyan Ding, Xiaoyan Ding
Publicado 2021

Visual Outcome and Treatment Frequency of Anti-VEGF Therapy Using the Treat-and-Extend and Treatment Cessation Regimen for Exudative Age-Related Macular Degeneration and Pachychoro...

por Kinoshita T, Mori J, Hatanaka A, Shimizu M, Imaizumi H
Publicado 2021

Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice

por Andrea Montesel, Claudio Bucolo, Ferenc B. Sallo, Chiara M. Eandi
Publicado 2021